Andrii Diachenko: Difference between revisions
Expand verified author records and publication-linked research network |
Add complete multilingual reference and language navigation |
||
| Line 1: | Line 1: | ||
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Andrii Diachenko|English]] · [[Andrii Diachenko/uk|Українська]] · [[Andrii Diachenko/es|Español]] · [[Andrii Diachenko/fr|Français]] · [[Andrii Diachenko/de|Deutsch]] · [[Andrii Diachenko/pt|Português]]</div> | |||
'''Andrii Diachenko''' is a contributor to the publications documented in this wiki. The ORCID distinguishes the contributor represented here from namesakes. | '''Andrii Diachenko''' is a contributor to the publications documented in this wiki. The ORCID distinguishes the contributor represented here from namesakes. | ||
Latest revision as of 00:52, 12 November 2026
Andrii Diachenko is a contributor to the publications documented in this wiki. The ORCID distinguishes the contributor represented here from namesakes.
Identity and public profiles
Dated institutional context
The September 2025 drug-policy article identifies Protecta as his affiliation. That dated article affiliation does not establish a current institutional office.
SRUMPL management record and the specific publications below provide the source context.
Selected publication connections
- With Oleksandr Veits, Valentyn Shapovalov and Valerii Shapovalov: comparative US/Ukraine drug-policy research (23 September 2025), publisher record.
- With Ivan Voloshyn-Haponov, Valerii Shapovalov and Natalia Matsko: the 2025 rehabilitation and forensic-pharmaceutical editorial, publisher record.
- With Valentyn Shapovalov and Anatolii Derkach: healthcare-system reform and legal relationships, publisher record. The landing page's publication date and PDF received date are inconsistent; the latter should not be used to construct a chronology.
Shared conceptual publications
The publisher records list this author among the six coauthors of The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration (12 December 2025) and Vision 2035 – Medico-Pharmaceutical Law for Human Security (6 March 2026). These bylines apply to those editions, not automatically to every later revision or conceptual article.
- 2025 monograph, DOI 10.53933/3qgntf55.
- 2026 book, DOI 10.53933/b91avw28.
Reading the record
Publication coauthorship, institutional office and contribution to an individual concept are different relationships. See Research network for dated, work-specific connections and People and attribution for editorial principles. Profile databases can contain duplicate records or name variants; the ORCID identifier is an identity key, not proof that every listed claim has been independently audited.